Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️
🚨READ IT
The Justice Department just secured a superseding indictment against the Southern Poverty Law Center, and it reveals some new bombshells
🧵1/20
https://t.co/uRCbnWaBzr
HE'S BACK AT IT AGAIN.
$NVDA CEO JENSEN HUANG KEEPS TELLING YOU HOW TO GET RICH.
IN 2025 HE CALLED:
$MU AT $64 → +1531.00%
$NVDA AT $88 → +156.27%
$AMD AT $79 → +556.84%
$TSM AT $140 → +228.57%
NOW IN 2026 HE'S BETTING ON SPACE.
$RKLB AT $126
$ASTS AT $113
$MRVL AT $275
$TSLA AT $421
Are you going to ignore him again?
If you're not following us with notifications turned on, you might miss our next alerts.
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
🚨 BOOM! Democrats face Electoral College DISASTER, even CNN is now sounding the alarm that Trump states like TX, FL, NC, GA and AZ are GAINING electoral seats at the next census.
...while CA, NY, IL, NJ, MA LOSE seats.
RE-DO THE CENSUS! Exclude illegals!
🚨 BOMBSHELL DEVELOPMENT: Newsmax is publicly calling for, and actually demanding the arrest of Barack Obama and all of his co-conspirators, including Hillary Clinton, who hatched the plan to overthrow the U.S. government and the will of the American people!
FOLLOW ME, THE NEXT DROP WILL BE SHOCKING
I’ll only say this once.
This might be the fastest realistic way to build serious wealth by the end of 2026.
My updated AI & Frontier Tech Watchlist (Today’s Hot Stocks Edition):
$SOUN — $8 Must Buy
$IONQ — $63 Must Buy
$ENVX — $6.6 Must Buy
$INOD — $95 Must Buy
$EOSE — $8 Must Buy
$QBTS — $28 Must Buy
Here’s why each one belongs here:
$SOUN: Voice AI leader powering real-time conversational AI across autos, restaurants, and devices. Explosive adoption.
$IONQ: Trapped-ion quantum computing hardware and cloud leader. One of the purest quantum plays scaling fast.
$ENVX: Silicon anode battery technology unlocking higher energy density for AI data centers and EVs.
$INOD: AI-powered data pipeline and infrastructure provider seeing massive hyperscaler demand.
$EOSE: Long-duration zinc batteries for grid-scale AI power storage. Multiple supply deals already secured.
$QBTS: Quantum computing company with growing commercial traction and government contracts.
No hype. No lottery tickets. Just real companies building the AI, quantum, battery storage, and data infrastructure layers of the next decade.
They keep asking why I don’t charge for this.
Simple: I’ve made enough. Sharing conviction plays I actually believe in is my hobby now.
Save this post. Check back December 2026.
NFA
The more salt you eat, the less likely you are to have a heart attack and high blood pressure…
This is according to the largest study EVER published on this.
BOMBSHELL REVELATION: Hidden cameras show Former MI Senate Majority Leader, Mike Shirkey, unveiled the TRUTH about January 6:
“It was all staged. Mitch McConnell wanted it to be a mess so he could secure a Trump impeachment conviction for Pelosi and Schumer.”